Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Certain cancer drugs can cause skin issues like rashes and itching.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Topical sensitizers have mixed success in treating alopecia areata.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Cold Plasma shows promise for healing wounds by killing bacteria and helping tissue grow.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Herbal remedies may help with hair loss but need more research.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Platelet-Rich Plasma (PRP) has potential benefits in plastic surgery, especially for skin grafts, wound healing, hair loss, mild Carpal Tunnel Syndrome, and TMJ disorders, but more research is needed to confirm its effectiveness.

PCOS affects many young women in KSA, with mild cases being most common.

Finasteride's link to depression is questionable due to study flaws and potential bias.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Combining modern and Unani medicine may better manage PCOS symptoms.

Certain hairstyles increase the risk of scalp and hair disorders in African American girls.

Nails can reveal important health information about skin and body conditions.

PRP treatment helps hair growth in most cases, but more research needed.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Most low-level light therapy studies did not accurately report how light was measured, affecting treatment reliability.